Stephen Prouty

Dr. Prouty joined Follica in May, 2006.
As Director of Research, Dr. Prouty oversees Follica’s preclinical and human proof-of-concept clinical research programs.
Prior to joining Follica, Dr. Prouty oversaw diverse research programs at Johnson & Johnson as a Staff Scientist for 4 years and a Principal Scientist for 9 years.
While at the Skin Biology Research Center of Johnson & Johnson Consumer Products WorldWide, Dr. Prouty worked with Dr. Kurt Stenn on numerous dermatology-focused programs.
Dr. Prouty’s research resulted in the cloning and characterization of the gene for human stearoyl-CoA desaturase, as well as the discovery of novel enzymatic reactions for other members of the desaturase gene family in sebaceous glands, a novel regulator of acne.
Dr. Prouty then joined J&J’s Enterology Team where he developed and managed drug and biomarker discovery projects for diseases of the gastrointestinal tract, including Crohn’s disease, ulcerative colitis, and irritable bowel syndrome.
Dr. Prouty obtained his Ph.D.
in Anatomy/Neurobiology from Medical College of Pennsylvania and completed his postdoctoral training at Yale University School of Medicine, where he was awarded an American Cancer Society Fellowship